Loading chat...

CA SB367

Bill

Status

Passed

8/29/2022

Primary Sponsor

Melissa Hurtado

Click for details

Origin

Senate

2021-2022 Session

AI Summary

  • Community college districts and California State University trustees must provide educational information about opioid overdose and opioid overdose reversal medication (naloxone) as part of campus orientations, in collaboration with recovery advocacy organizations.

  • Community college districts and California State University trustees must require campus health centers to apply for use of the statewide standing order issued by the State Public Health Officer to distribute federally approved opioid overdose reversal medication.

  • Campus health centers must apply to participate in the Naloxone Distribution Project administered by the State Department of Health Care Services and distribute naloxone obtained through the project upon approval.

  • The University of California Regents are requested, but not required, to comply with the same educational and medication distribution requirements.

  • If the Commission on State Mandates determines this bill imposes state-mandated costs on local agencies, reimbursement shall be made pursuant to existing statutory procedures.

Legislative Description

Student safety: opioid overdose reversal medication.

Last Action

Chaptered by Secretary of State. Chapter 218, Statutes of 2022.

8/29/2022

Committee Referrals

Appropriations6/29/2022
Health6/15/2022
Higher Education6/2/2022
Rules6/17/2021
Higher Education5/20/2021
Appropriations4/8/2021
Health3/22/2021
Education2/17/2021
Rules2/10/2021

Full Bill Text

No bill text available